118 related articles for article (PubMed ID: 28947943)
1. Heteronanoparticles by self-Assembly of Doxorubicin and Cyclopamine Conjugates.
Fumagalli G; Stella B; Pastushenko I; Ricci F; Christodoulou MS; Damia G; Mazza D; Arpicco S; Giannini C; Morosi L; Dosio F; Sotiropoulou PA; Passarella D
ACS Med Chem Lett; 2017 Sep; 8(9):953-957. PubMed ID: 28947943
[TBL] [Abstract][Full Text] [Related]
2. Heteronanoparticles by Self-Assembly of Ecdysteroid and Doxorubicin Conjugates To Overcome Cancer Resistance.
Fumagalli G; Giorgi G; Vágvölgyi M; Colombo E; Christodoulou MS; Collico V; Prosperi D; Dosio F; Hunyadi A; Montopoli M; Hyeraci M; Silvani A; Lesma G; Via LD; Passarella D
ACS Med Chem Lett; 2018 May; 9(5):468-471. PubMed ID: 29795761
[TBL] [Abstract][Full Text] [Related]
3. Coadministration of Polymeric Conjugates of Docetaxel and Cyclopamine Synergistically Inhibits Orthotopic Pancreatic Cancer Growth and Metastasis.
Almawash SA; Mondal G; Mahato RI
Pharm Res; 2018 Jan; 35(1):17. PubMed ID: 29305793
[TBL] [Abstract][Full Text] [Related]
4. Self-assembly of porphyrin-grafted lipid into nanoparticles encapsulating doxorubicin for synergistic chemo-photodynamic therapy and fluorescence imaging.
Hameed S; Bhattarai P; Liang X; Zhang N; Xu Y; Chen M; Dai Z
Theranostics; 2018; 8(19):5501-5518. PubMed ID: 30555560
[TBL] [Abstract][Full Text] [Related]
5. GE11 peptide modified and reduction-responsive hyaluronic acid-based nanoparticles induced higher efficacy of doxorubicin for breast carcinoma therapy.
Hu D; Mezghrani O; Zhang L; Chen Y; Ke X; Ci T
Int J Nanomedicine; 2016; 11():5125-5147. PubMed ID: 27785019
[TBL] [Abstract][Full Text] [Related]
6. [Zinc-modified Nanotransporter for Target Drug Therapy of Breast Cancer].
Skaličková S; Gargulák M; Löffelmann M; Ruttkay-Nedecký B; Kepinská M; Parák T; Kizek R
Klin Onkol; 2017; 30(Supplementum1):174-176. PubMed ID: 28471199
[TBL] [Abstract][Full Text] [Related]
7. Albumin Binding Domain Fusing R/K-X-X-R/K Sequence for Enhancing Tumor Delivery of Doxorubicin.
Liu L; Zhang C; Li Z; Wang C; Bi J; Yin S; Wang Q; Yu R; Liu Y; Su Z
Mol Pharm; 2017 Nov; 14(11):3739-3749. PubMed ID: 28950700
[TBL] [Abstract][Full Text] [Related]
8. Improved antitumor activity and reduced toxicity of doxorubicin encapsulated in poly(ε-caprolactone) nanoparticles in lung and breast cancer treatment: An in vitro and in vivo study.
Cabeza L; Ortiz R; Prados J; Delgado ÁV; Martín-Villena MJ; Clares B; Perazzoli G; Entrena JM; Melguizo C; Arias JL
Eur J Pharm Sci; 2017 May; 102():24-34. PubMed ID: 28219748
[TBL] [Abstract][Full Text] [Related]
9. Facile fabrication of a novel hybrid nanoparticles by self-assembling based on pectin-doxorubicin conjugates for hepatocellular carcinoma therapy.
Ye PJ; Huang C; Yang S; Gao P; Li ZP; Tang SY; Xiang Y; Liu YF; Chen YP; He DX; Yu CY
Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S661-S670. PubMed ID: 30307317
[TBL] [Abstract][Full Text] [Related]
10. Reduction Responsive Self-Assembled Nanoparticles Based on Disulfide-Linked Drug-Drug Conjugate with High Drug Loading and Antitumor Efficacy.
Song Q; Wang X; Wang Y; Liang Y; Zhou Y; Song X; He B; Zhang H; Dai W; Wang X; Zhang Q
Mol Pharm; 2016 Jan; 13(1):190-201. PubMed ID: 26629710
[TBL] [Abstract][Full Text] [Related]
11. Ovatodiolide sensitizes aggressive breast cancer cells to doxorubicin, eliminates their cancer stem cell-like phenotype, and reduces doxorubicin-associated toxicity.
Bamodu OA; Huang WC; Tzeng DT; Wu A; Wang LS; Yeh CT; Chao TY
Cancer Lett; 2015 Aug; 364(2):125-34. PubMed ID: 25976769
[TBL] [Abstract][Full Text] [Related]
12. pH-Responsive prodrug nanoparticles based on a sodium alginate derivative for selective co-release of doxorubicin and curcumin into tumor cells.
Gao C; Tang F; Gong G; Zhang J; Hoi MPM; Lee SMY; Wang R
Nanoscale; 2017 Aug; 9(34):12533-12542. PubMed ID: 28819666
[TBL] [Abstract][Full Text] [Related]
13. Characterization of drug release from fibrin gels loaded with different pharmaceutical and experimental doxorubicin formulations.
Viale M; Monticone M; Maric I; Giglio V; Profumo A; Aprile A; Cilli M; Abelmoschi ML; Rocco M
Pharmacol Rep; 2018 Aug; 70(4):760-765. PubMed ID: 29936363
[TBL] [Abstract][Full Text] [Related]
14. The effect of the plasticizer diethylhexyl phthalate on transport activity and expression of P-glycoprotein in parental and doxo-resistant human sarcoma cell lines.
Angelini A; Centurione L; Sancilio S; Castellani ML; Conti P; Di Ilio C; Porreca E; Cuccurullo F; Di Pietro R
J Biol Regul Homeost Agents; 2011; 25(2):203-11. PubMed ID: 21880209
[TBL] [Abstract][Full Text] [Related]
15. Mulberry-like dual-drug complicated nanocarriers assembled with apogossypolone amphiphilic starch micelles and doxorubicin hyaluronic acid nanoparticles for tumor combination and targeted therapy.
Li K; Liu H; Gao W; Chen M; Zeng Y; Liu J; Xu L; Wu D
Biomaterials; 2015 Jan; 39():131-44. PubMed ID: 25477180
[TBL] [Abstract][Full Text] [Related]
16. The activity against Ehrlich's ascites tumors of doxorubicin contained in self assembled, cell receptor targeted nanoparticle with simultaneous oral delivery of the green tea polyphenol epigallocatechin-3-gallate.
Ray L; Kumar P; Gupta KC
Biomaterials; 2013 Apr; 34(12):3064-76. PubMed ID: 23357370
[TBL] [Abstract][Full Text] [Related]
17. Reduced in vivo toxicity of doxorubicin by encapsulation in cholesterol-containing self-assembled nanoparticles.
Gonzalez-Fajardo L; Mahajan LH; Ndaya D; Hargrove D; Manautou JE; Liang BT; Chen MH; Kasi RM; Lu X
Pharmacol Res; 2016 May; 107():93-101. PubMed ID: 26976795
[TBL] [Abstract][Full Text] [Related]
18. Self-Assembled Cationic Biodegradable Nanoparticles from pH-Responsive Amino-Acid-Based Poly(Ester Urea Urethane)s and Their Application As a Drug Delivery Vehicle.
He M; Potuck A; Kohn JC; Fung K; Reinhart-King CA; Chu CC
Biomacromolecules; 2016 Feb; 17(2):523-37. PubMed ID: 26650653
[TBL] [Abstract][Full Text] [Related]
19. Folic acid magnetic nanotheranostics for delivering doxorubicin: Toxicological and biocompatibility studies on Zebrafish embryo and larvae.
Igartúa DE; Azcona PL; Martinez CS; Alonso SDV; Lassalle VL; Prieto MJ
Toxicol Appl Pharmacol; 2018 Nov; 358():23-34. PubMed ID: 30205093
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo evaluation of doxorubicin conjugates with the divalent peptide E-[c(RGDfK)2] that targets integrin alphavbeta3.
Ryppa C; Mann-Steinberg H; Fichtner I; Weber H; Satchi-Fainaro R; Biniossek ML; Kratz F
Bioconjug Chem; 2008 Jul; 19(7):1414-22. PubMed ID: 18578486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
